| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 610 | 1.684 | 12.538 | 25.639 | 25.443 | 1.129 | 25.124 |
| Total Income - EUR | - | - | - | 610 | 1.684 | 12.538 | 25.639 | 25.623 | 2.187 | 25.124 |
| Total Expenses - EUR | - | - | - | 89 | 0 | 4.720 | 15.660 | 15.894 | 11.500 | 7.464 |
| Gross Profit/Loss - EUR | - | - | - | 520 | 1.684 | 7.818 | 9.979 | 9.729 | -9.313 | 17.660 |
| Net Profit/Loss - EUR | - | - | - | 502 | 1.634 | 7.458 | 9.303 | 8.975 | -9.313 | 14.622 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Sonogastromed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 24.878 | 15.204 | 6.100 | 0 | 0 |
| Current Assets | - | - | - | 778 | 2.201 | 7.873 | 12.547 | 3.848 | 1.447 | 14.982 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 8 |
| Receivables | - | - | - | 0 | 0 | 72 | 83 | 0 | 27 | 503 |
| Cash | - | - | - | 778 | 2.201 | 7.802 | 12.465 | 3.848 | 1.420 | 14.471 |
| Shareholders Funds | - | - | - | 545 | 2.168 | 7.500 | 16.636 | 9.016 | -324 | 14.300 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 233 | 33 | 25.252 | 11.115 | 932 | 1.771 | 683 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Sonogastromed S.r.l.